Caricamento...
Effects of fenofibrate on atherogenic dyslipidemia in hypertriglyceridemic subjects
Background: The metabolic syndrome (MS) is often accompanied by atherogenic dyslipidemia, which is characterized by elevated triglycerides (TG), reduced high‐density lipoprotein cholesterol (HDL‐C), and elevated numbers of small, dense low‐density lipoprotein(LDL) particles. Hypothesis: It was hypot...
Salvato in:
| Pubblicato in: | Clin Cardiol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley Periodicals, Inc.
2006
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6653967/ https://ncbi.nlm.nih.gov/pubmed/16796078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960290609 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|